Resumo

LAZO ROBLEJO, Yaily  e  LORES DELGADO, Danneris. Incretins: a new therapeutic alternative for the glycometabolic control of the type 2 diabetes mellitus. MEDISAN [online]. 2012, vol.16, n.3, pp.445-451. ISSN 1029-3019.

There are now newer treatments to control temporarily the blood glucose levels of most patients with type 2 diabetes mellitus. Among these therapeutic agents are those that replicate or potentiate the effect of incretins as agonists of glucagon-related peptide-1 and dipeptidyl peptidase-4 inhibitors, which have advantages such as eliminating manifestations of hypoglycemia and neutral effect or decreased body weight. Nevertheless, conclusive clinical data that demonstrate their effectiveness will be provided over time.

Palavras-chave : type 2 diabetes mellitus; incretins; glycometabolic control; glucagon-related peptide1; dipeptidyl peptidase-4.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )